Print Page | Sign In | Register
COVID-19: PPE, Supplies & Services


  • Demobilization of Battelle CCDS: On June 23, Louisiana demobilized the Battelle Critical Care Decontamination System (CCDS), because the existing contract on behalf of HHS and FEMA expired. Though Battelle will no longer decontaminate N95 respirators for the novel coronavirus through this federal contract, facilities that wish to continue to recycle masks should contact Battelle directly at 800-201-2011 or for pricing information.
  • Important Notice for Hospitals: To request PPE from the limited state cache, hospitals can call the State Supply Hotline at 225-325-5900 to be added to a list as supplies become available. This line is open 7 days a week from 8:00 a.m. to 5:00 p.m. CST. This information was included in the PPE Request Process provided by LDH on March 20.
  • Important Notice for Hospitals: PPE supplies remain limited; therefore, please continue to stay in contact with your vendors. At this time, we are anticipating very limited state/national assistance with PPE, and it is our understanding that the majority of the SNS is being redirected to testing sites, leaving only a small quantity for states to distribute to hospitals.
  • PPE Sequencing: LDH has provided a resource  that illustrates the sequence for putting on PPE and safely removing it.


  • FDA Webpage for Health Professionals: View the FDA's online compendium webpage of COVID-19 resources for healthcare professionals, which provides useful information on several issues, including EUAs, PPE and medical products, including investigational drugs and fraudulent devices.
  • FDA EUA Listing: View the FDA’s Emergency Use Authorizations (EUAs) webpage . The FDA Commissioner may allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when there are no adequate, approved, and available alternatives.
  • Guidance on Non-Invasive Monitoring Devices: On June 5, the FDA released new guidance that expands for the duration of the COVID-19 emergency the availability and capability of non-invasive monitoring devices. This replaces guidance issued March 20, and includes additional device types and offers more references and standards. The FDA said remote devices reduce patient and healthcare provider contact, ultimately limiting possible COVID-19 exposure.
  • Hand Sanitizer Availability: On June 1, the FDA updated guidance to spur wider availability of alcohol-based hand sanitizers during the pandemic. The agency’s temporary guidance clarifies interim levels of certain impurities that can be present in the ethanol used to produce alcohol-based hand sanitizer products during the public health emergency. The FDA encourages consumers, manufacturers or distributors to email their questions regarding hand sanitizers to or review the agency’s FAQs.
  • Proper N95 Sterilization Processes: On May 27, the FDA issued a reminder to healthcare facilities’ reprocessing staffs to follow the agency-outlined decontamination cycle when using the ASP STERRAD Sterilization System to decontaminate N95 or N95-equivalent respirators for reuse via vaporized hydrogen peroxide to ensure continued safe use of the device.

  • PPE Donning and Doffing Resource: The New England Journal of Medicine posted a video demonstrating a procedure for putting on and removing one type of PPE that has been recommended by the CDC for use in U.S. hospitals to minimize the risk of exposure to infectious material while caring for patients with COVID-19.

  • Pharmacy Compounders: On May 14, the FDA updated its guidance for pharmacy compounders’ use of PPE. The guidance clarifies that intended-sterile drugs can be compounded in segregated compounding areas that are not within cleanrooms, assuming specific beyond-use dates are utilized. The agency said it adopted this policy to help assure patients’ access to necessary medications while reducing the risks of compounding when standard PPE are not available.
  • OSHA Guidance: On April 24, OSHA issued interim enforcement guidance outlining a host of methods for decontaminating N95 and other filtering-facepiece respirators during the COVID-19 pandemic. The guidance indicates that OSHA will, on a case-by-case basis, exercise enforcement discretion related to the reuse of decontaminated respirators consistent with the conditions outlined in this interim enforcement guidance.
  • Propofol Drug Products: On April 22, the FDA issued guidance allowing pharmacies and outsourcing facilities to repackage, under certain conditions and during the public health emergency, FDA-approved propofol drug products for hospitals having difficulty obtaining adequate supplies in the sizes they use to support or treat patients with COVID-19.
  • Presource Packs Recall: Cardinal Health recently initiated a voluntary recall for specific production lots of single-sterile and bulk non-sterile Cardinal Health Non-Reinforced Surgical Gowns, Cardinal Health Fabric-Reinforced Surgical Gowns and RoyalSilk Non-Reinforced Surgical Gowns. For more information, view the FAQ document regarding single-sterile/BNS alternative kitter affected lot. 
  • Reusable Elastomeric Respirators: The CDC released contingency and crisis capacity strategies for the cleaning, decontamination and use of reusable elastomeric respirators during surge demand situations. The agency also updated its webpage on decontaminating and reusing disposable facepiece respirators to clarify the language on individual facility discretion to determine what decontamination method to use, certain decontamination methods and emergency use authorizations.
  • Fraudulent 3M PPE: On April 21, the FBI released a guide to help the healthcare sector identify and report fraudulent 3M brand PPE, including N95 respirators.
  • PPE Distribution Effort: On April 14, a coalition of private and nonprofit organizations, including the AHA, Kaiser Permanente, Kearney, Merit Solutions, Microsoft, and UPS, launched Protecting People Everywhere, an initiative powered by the HealthEquip app through which PPE donors and their donations can be matched with potential recipients. Hospitals and health systems can register and submit requests for PPE at For more information, view the video guide and FAQs document.
  • Ventilator Distribution Effort: On April 14, the AHA disseminated a Special Bulletin announcing the “Dynamic Ventilator Reserve,” a new online inventory database of ventilators and associated supplies, such as tubing and filters, that are available to lend to other facilities in the country. Hospitals and health systems that would like to participate in the virtual network can get more information by contacting the AHA at 800-424-4301.

  • CDC Conservation Strategies: Strategies for optimizing PPE supplies, including eye protection, isolation gowns, facemasks and N95 respirators
  • Pharmacy PPE Use: On April 10, the FDA issued temporary guidance for pharmacies’ preservation of limited supplies of PPE.  
  • N95 Respirator Guidance & Strategies

  • FAQs: On April 5, the FDA released an FAQ document clarifying recent revisions to its face mask and respirator enforcement guidance stating that the agency will allow the use of respirators approved under standards used in other countries for the duration of the COVID-19 pandemic.

  • Potential Risks: ECRI updated its clinical evidence assessment  on the potential risks and benefits of N95 respirator reuse or extended use.

  • Guidance: The FDA has revised its face mask and respirator guidance to provide significant, additional enforcement discretion for personal protective equipment (PPE) that is not subject to COVID-19 emergency use authorization. The FDA says it “recognizes that, when alternatives, such as FDA-cleared masks or respirators, are unavailable, individuals, including healthcare professionals, might improvise PPE. FDA does not intend to object to individuals’ distribution and use of improvised PPE when no alternatives, such as FDA-cleared masks or respirators, are available.”

  • Decontaminating FFRs: On April 1, CDC issued guidance on decontaminating disposable filtering facepiece respirators for reuse during times of contingency and crisis capacity. CDC does not recommend that FFRs be decontaminated and then reused as standard care but rather as an option that may need to be considered when FFR shortages exist.

  • OSHA Guidance: On March 14, OSHA released guidance flexibility with N95 respirator fit-testing.

  • FDA Surgical Mask and Gown Conservation Strategies: On March 11, FDA released a letter to healthcare providers.

  • Cloth Face Mask Guidance: On April 3, the CDC recommended that the general public use simple cloth face coverings/masks to slow the spread of the virus. The CDC further stated that surgical masks and N-95 respirators should be reserved for healthcare workers and other medical first responders.

  • FDA Ventilator Guidance:

  • Action to Increase Ventilators and Ventilator Supplies: On March 27, the FDA released a statement for the most up-to-date actions it has taken to help increase the supply of ventilators, ventilator tubing connectors, ventilator accessories, and filtering facepiece respirators.
  • Guidance to Mitigate Ventilator Supply Disruptions: On March 23, the FDA released updated guidance to provide flexibility and expand the availability of ventilators and other respiratory devices to treat patients during the public health emergency.
  • Ventilator Supply Mitigation Strategies: On March 22, the FDA released a letter to healthcare providers regarding ventilator suppl mitigation strategies.
  • Emergency Vent Sharing Protocol: On March 26, the Assistant Secretary for Preparedness and Response sent state emergency preparedness personnel the  Emergency Ventilator Sharing Protocol from Mount Sinai Health System. 
  • Importing/Exporting PPE: On April 10, FEMA issued a temporary rule to bar the exportation of some PPE, including some respirators and surgical masks and gloves. On March 24, the FDA adjusted its import screening to expedite access to personal PPE and clarified types of PPE that can be imported without engaging with the FDA. To provide flexibility, the FDA will facilitate access to critical legitimate PPE and devices, and monitor the import systems to prevent and mitigate potential issues. The FDA established an email,, for industry representatives to address questions or concerns.
  • FDA Contact Number: Regarding Supplier Information for PPE: 1-888-INFO-FDA
  • AHA 100 Million Mask Challenge: Is a national initiative to secure millions of masks for the physicians, nurses and caregivers who are treating coronavirus patients and who are at greater risk because of a nationwide shortage of PPE. The effort will facilitate private sector partnerships to address these shortages. AHA has added new tools and guidance, including specs for masks and other needed equipment such as face shields and ventilators. For more information and the latest resources to support the challenge, visit AHA’s webpage .

STATE Vendor List:


  • Aya Healthcare: Hospital Staffing
    Contact: Bob Murphy; 561-479-7336;
    • Staffing Solutions: Aya Healthcare, the parent company of the LHA-endorsed staffing partner, Symmetry Workforce Solutions, has been pipelining nurses and allied health workers for weeks in preparation for outbreaks of the coronavirus in hotspots throughout the U.S. They have crisis teams working 24/7 to respond to any need our members have and have already helped several Louisiana hospitals. Call or email Bob Murphy at 561-479-7336 or  for more information.
  • Intalere: Test Kits, Ventilators and N95 Mask
    Contact: C. J. Tuminello; 225-937-3032;
    • Intalere has introduced the Post-COVID Transformation Toolkit to help members in making up for lost revenue and depleted cash flow, and in adapting to new market forces. For more information, contact C.J. Tuminello.
    • View Update focused on solutions regarding infection prevention, laboratory, supplier vetting, supply chain and others.
    • View Update focused on solutions regarding infection prevention, behavioral health, recovery and reopening, and other valuable resources, along with information on ALLAVO hand sanitizer.
    • View Update focused on solutions regarding COVID-19 testing resources, PPE alternatives, and cleaning and disinfection. 
    • Intalere, a ShareCor-endorsed vendor, created a COVID-19 Supplier Guide & Directory to help members navigate through some of the Intalere resources that they may need while managing this crisis. 
  • Jackson Physician Search: Physician Placement Services
    Contact: Gary Seaberg; Office: 469-909-6681; Cell/Text: 469-203-7256 
    • Special Recruitment Incentives: As LHA’s ShareCor-endorsed physician recruitment partner, Jackson Physician Search is working one-on-one with Louisiana hospitals to offer creative fee structures that will ensure facilities are able to meet patient demand in the future, while being sensitive to the financial realities many are currently facing. For more information, contact Jackson Physician Search Director Gary Seaberg at or 469-909-6681. Jackson Physician Search also released a paper on “Five Ways to Move the Needle on the Physician Shortage,” which includes key approaches the company believes will be front and center in upcoming industry discussions.
  • Merritt Hawkins: Nursing and Physician Staffing Services
    Contact: Cristina Campanella; Office: 770-481-1120; Cell: 404-314-3706
    • AMN Healthcare has recently launched a COVID-19-specific website providing innovative technology, resources and solutions for accessing all nursing and allied professionals, physicians, and advanced practice professionals.
  • SunRX: Provides a letter and a flier that addresses two specific 340B solutions: 1) Implementing a 340B Discount Card to provide access to 340B pricing for the uninsured; and 2) Evaluating your 340B pharmacy program for optimal financial performance. SUNRx can provide your clients with a no‐obligation assessment for your 340B program


  • Sen. Cassidy PPE Request: On April 7, Sen. Bill Cassidy signed onto a letter asking President Trump to use his authority under the Defense Production Act to incentivize private firms to produce more PPE.
  • Federal Notice: On March 30, HHS issued a notice under Executive Order 13910 and section 102 of the Defense Production Act of 1950, as amended, designating health and medical resources necessary to respond to the spread of COVID-19 that are scarce or the supply of which would be threatened by excessive accumulation. These designated materials are subject to the hoarding prevention measures authorized under the Executive Order and the Act.
  • Joint Commission Statement on Face Masks: On March 31, the Joint Commission issued a statement that supports “allowing staff to bring their own standard face masks or respirators to wear at work when their healthcare organizations cannot routinely provide access to protective equipment that is commensurate with the risk to which they are exposed.”
Louisiana Hospital Association

9521 Brookline Avenue, Baton Rouge, LA 70809  Google Map
Phone: (225) 928-0026
Fax: (225) 923-1004